The Department carried out a public consultation on possible solutions to the complex pavement parking problem, which ran from 31 August 2020 to 22 November 2020. Members of the public, including many who identified as having mobility or vision impairments, and organisations including those representing people with disabilities, participated. The consultation received over 15,000 responses. The Department has been carefully analysing the consultation responses and will publish the findings as soon as possible.<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4580", "label" : {"_value" : "Biography information for Baroness Vere of Norbiton"} } , "answeringMemberPrinted" : {"_value" : "Baroness Vere of Norbiton"} , "dateOfAnswer" : {"_value" : "2021-09-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL2640"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-09-20T15:36:18.207Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2021-09-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Parking: Pedestrian Areas"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what they are doing to combat the problem of pavement parking, which especially causes issues for those with sight or mobility impairments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4282", "label" : {"_value" : "Biography information for Lord Bourne of Aberystwyth"} } , "tablingMemberPrinted" : [{"_value" : "Lord Bourne of Aberystwyth"} ], "uin" : "HL2641"} , {"_about" : "http://data.parliament.uk/resources/1184996", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1184996/answer", "answerText" : {"_value" : "
The government is committed to ensuring that the UK has a robust framework for regulating financial services and that consumers are treated fairly. There are a range of existing rules in this area and there is work underway to address \u2018liquidity mismatch\u2019 in open-ended funds and to protect consumers.<\/p>
<\/p>
Financial services firms are required to treat customers fairly under rules set by the Financial Conduct Authority (FCA), and the FCA is responsible for overseeing the conduct standards of financial services firms. There are already a number of rules on eligible assets, which aim to protect consumers. Such rules apply to both types of fund that can be sold to retail investors \u2013 UCITS and non-UCITS retail schemes. Additionally, in September, the FCA published a policy response to their consultation on illiquid assets and open-ended funds. This outlined new rules for certain structures that invest in illiquid assets, which will come into effect in September 2020. The new rules will include a requirement that non-UCITS retail schemes investing in inherently illiquid assets must suspend dealing where the independent valuer determines there is material uncertainty regarding the value of more than 20% of the fund\u2019s assets. The FCA is also currently working with the Bank of England\u2019s Financial Policy Committee to assess how funds\u2019 redemption terms might be better aligned with the liquidity of their assets.<\/p>
<\/p>
Fund suspensions can be a necessary safety feature which ensures that a fund is not forced to sell assets at a distressed market price, which would lead to further losses for end investors in the fund. FCA rules permit suspensions, which may last for as long as is necessary to protect the interests of the remaining investors in the fund.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4689", "label" : {"_value" : "Biography information for Lord Agnew of Oulton"} } , "answeringMemberPrinted" : {"_value" : "Lord Agnew of Oulton"} , "dateOfAnswer" : {"_value" : "2020-03-26", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL2640"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-03-26T15:41:22.127Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "Treasury"} , "date" : {"_value" : "2020-03-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Financial Services"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have to issue guidance to (1) unit trust, and (2) open-ended investment company, managers to limit fund redemptions instead of obliging fund managers to be forced sellers of shares and bonds.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3869", "label" : {"_value" : "Biography information for Lord Myners"} } , "tablingMemberPrinted" : [{"_value" : "Lord Myners"} ], "uin" : "HL2585"} , {"_about" : "http://data.parliament.uk/resources/421268", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/421268/answer", "answerText" : {"_value" : "
A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.<\/p>
Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, The Diagnosis and Management of Primary Hypothyroidism<\/em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.<\/p> The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid\u2010stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the UK Guidelines for the Use of Thyroid Function Tests<\/em> published by the BTA.<\/p> The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.<\/p> The guidance remains up-to-date and a statement from the BTA Executive Committee supporting the existing guidelines was published in May 2015 in Clinical Endocrinology<\/em> and endorsed by the Association for Clinical Biochemistry and Laboratory Medicine, the BTF, the RCP and the SOE. The full statement is attached and available online at:<\/p> http://onlinelibrary.wiley.com/doi/10.1111/cen.12824/full<\/a><\/p> Regarding international guidance and harmonisation on approaches to testing, the existing United Kingdom guidelines have now been supported by new guidance published in the United States of America which draws on the latest research and available evidence on the management of the condition. The USA guidance also includes a section on the ethics of prescribing thyroid hormone combination therapies when the potential long-term harmful effects are not known.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"}
, "attachment" : [{"_about" : "http://data.parliament.uk/resources/421268/answer/attachment/1", "fileName" : {"_value" : "Okosieme_et_al-2015-Clinical_Endocrinology.pdf"}
, "title" : "Clinical Endocrinology paper"}
, {"_about" : "http://data.parliament.uk/resources/421268/answer/attachment/2", "fileName" : {"_value" : "the-diagnosis-and-management-of-primary-hypothyroidism-revised-statement-14-june-2011_2.pdf"}
, "title" : "Royal College of Physicians guidance"}
, {"_about" : "http://data.parliament.uk/resources/421268/answer/attachment/3", "fileName" : {"_value" : "TFT_guideline_final_version_July_2006.pdf"}
, "title" : "UK Guidelines Thyroid Function Tests"}
], "dateOfAnswer" : {"_value" : "2015-10-27", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL2640"}
, {"_value" : "HL2641"}
, {"_value" : "HL2642"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2015-10-27T17:53:42.837Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2015-10-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hypothyroidism"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty\u2019s Government what steps they have taken to help patients with undiagnosed hypothyroidism who present clinical signs and symptoms of that condition, but are refused any treatment as their blood test results remain normal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/457", "label" : {"_value" : "Biography information for Lord Pendry"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Pendry"}
], "uin" : "HL2639"}
, {"_about" : "http://data.parliament.uk/resources/421270", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/421270/answer", "answerText" : {"_value" : " A blood test measuring hormone levels is the only accurate way to find out if there is a thyroid problem.<\/p> Best practice on the identification and management of hypothyroidism has been set out by the Royal College of Physicians (RCP) in its guidance, The Diagnosis and Management of Primary Hypothyroidism<\/em>, first published in 2008. The guidance, which is attached, was developed on behalf of key organisations, including the British Thyroid Association (BTA), the British Thyroid Foundation (BTF) and the Society for Endocrinology (SOE), and is endorsed by the Royal College of General Practitioners. A copy of the UK Guidelines is attached.<\/p> The RCP guidance sets out that the only validated method of testing thyroid function is through a blood sample, which must include measurement of the levels of thyroid\u2010stimulating hormone (TSH) and free thyroxine (FT4) in serum, as recommended in the UK Guidelines for the Use of Thyroid Function Tests<\/em> published by the BTA.<\/p> The RCP guidelines set out that overwhelming evidence supports the use of thyroxine hormone replacement (T4 or tetra-iodothyronine) alone in the treatment of hypothyroidism, with this usually being prescribed as levothyroxine. However, this does not prevent clinicians considering other forms of thyroid hormone replacement if appropriate.<\/p>